Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Xa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01051778
What this trial is testing

Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome

Who this might be right for
Recurrent Abortion
Cairo University 60
Not applicableLooking for participantsNCT07658989
What this trial is testing

Optimizing Anticoagulation in Pregnancies With Mechanical Heart Valves

Who this might be right for
PregnancyProsthetic Heart ValveAnticoagulant Therapy
Mount Sinai Hospital, Canada 100
Not applicableStudy completedNCT05771285
What this trial is testing

Cold Application on the Subcutaneous Injection

Who this might be right for
Injection Site BruisingBruisingPain
Yuksek Ihtisas University 78
Not applicableStudy completedNCT04268940
What this trial is testing

Thrombo-Elastography Guided Management of ECMO

Who this might be right for
Extracorporeal Circulation of Blood; Thrombocytopenia
Damian Ratano 61
Not applicableStudy completedNCT00781690
What this trial is testing

Reduction of Heparin Dose in Dialysis With Evodial System

Who this might be right for
Chronic Kidney Failure
Vantive Health LLC 53
Not applicableStudy completedNCT01559883
What this trial is testing

Study on Thrombosis Therapy in German Cancer Patients

Who this might be right for
CancerDeep Vein ThrombosisPulmonary Embolism
LEO Pharma 76
Not applicableStudy completedNCT06484231
What this trial is testing

Evaluation of the Effectiveness of Prophylactic LMWH by Thromboelastography

Who this might be right for
Malignancy
Ege University 25
Large-scale testing (Phase 3)Study completedNCT00171769
What this trial is testing

Atrial Fibrillation Feasibility Certoparin Trial - AFFECT

Who this might be right for
Persistent Nonvalvular Atrial Fibrillation
Novartis 200
Testing effectiveness (Phase 2)Ended earlyNCT01817257
What this trial is testing

Anticoagulation Length in Cancer Associated Thrombosis

Who this might be right for
CancerThrombosisVenous Thromboembolism+2 more
Cardiff University 2
Post-approval studies (Phase 4)Study completedNCT00077805
What this trial is testing

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Who this might be right for
Acute Ischemic Stroke
Sanofi
Testing effectiveness (Phase 2)Study completedNCT01419977
What this trial is testing

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Crisis
Duke University 34
Large-scale testing (Phase 3)Looking for participantsNCT07140211
What this trial is testing

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

Who this might be right for
Venous Thromboembolism (VTE)Postpartum
Marc Blondon 9,200
Not applicableLooking for participantsNCT07183605
What this trial is testing

Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients

Who this might be right for
Anticoagulants and Bleeding Disorders
Centre Hospitalier Régional d'Orléans 30
Post-approval studies (Phase 4)Study completedNCT00245856
What this trial is testing

Treatment of Upper Extremity Deep-Vein Thrombosis

Who this might be right for
Deep-Vein Thrombosis
University of Oklahoma 67
Not applicableUnknownNCT02898051
What this trial is testing

Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism

Who this might be right for
NeoplasmsVenous Thromboembolism
Assistance Publique - Hôpitaux de Paris 370
Not applicableStudy completedNCT01356615
What this trial is testing

Low Molecular Weight Heparin for Hemodialysis Anticoagulation

Who this might be right for
End Stage Renal Failure on Dialysis
Tehran University of Medical Sciences 27
Post-approval studies (Phase 4)Study completedNCT00794560
What this trial is testing

Self-management of Low Molecular Weight Heparin Therapy

Who this might be right for
Thromboembolism
University Hospital, Basel, Switzerland 154
Not applicableStudy completedNCT02719418
What this trial is testing

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses

Who this might be right for
Renal Insufficiency, ChronicDeep Venous Thrombosis, Protection Against
Maisonneuve-Rosemont Hospital 28
Large-scale testing (Phase 3)Study completedNCT00628576
What this trial is testing

Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities

Who this might be right for
Deep Venous Thrombosis
Aalborg University Hospital 99
Large-scale testing (Phase 3)Ended earlyNCT00031837
What this trial is testing

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerThromboembolism
Gary Morrow 400
Next Page